Clovis Oncology, Inc. Long-Term Debt, Maturity, Year Two
Clovis Oncology, Inc. had Long-Term Debt, Maturity, Year Two of $143.28 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2022-08-08
- 2022-06-30: Long-Term Debt, Maturity, Year Two $143.28M.
- 2022-03-31: Long-Term Debt, Maturity, Year Two $143.28M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2022-06-30 | $143.28M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $143.28M 10-Q · filed 2022-05-05 |